Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)   2013 , Volume 15 , Number 1; Page(s) 1 To 3.
 
Paper: 

HER2 ILE655VAL SINGLE NUCLEOTIDE POLYMORPHISM IN PATIENTS WITH OVARIAN CANCER

 
 
Author(s):  MOJTAHEDI ZAHRA, ERFANI NASROOLAH, MALEKZADEH MAHYAR, HAGHSHENAS MOHAMMAD REZA, GHADERI ABBAS, SAMSAMI DEHAGHANI ALAMTAJ*
 
* DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, SHIRAZ UNIVERSITY OF MEDICAL SCIENCES, SHIRAZ, IR IRAN
 
Abstract: 

Background: The association between HER2 Ile655Val single nucleotide polymorphism and cancer is controversial.
Objectives: The aim of our study was to investigate this polymorphism in patients with ovarian cancer.
Patients and Methods: Genomic DNA was extracted from peripheral blood leukocytes of 107 patients and 130 healthy women. HER2 gene polymorphism was assessed by PCR-RFLP.
Results: No significant difference was observed in genotype and allele frequency between patient and control groups according to HER2 Ile655Val polymorphism. The disease stage, age, and histological type were also not associated with the polymorphism.
Conclusions: our data showed that HER2 Ile655Val single nucleotide polymorphism was not significantly associated with onset, histological type, age, and stage of ovarian cancer in Iranian patients.

 
Keyword(s): CARCINOMA, ENDOMETRIOID, HER2, POLYMORPHISM, SINGLE NUCLEOTIDE
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 72
 
Latest on Blog
Enter SID Blog